Triastek’s 3D printed drug T21 shows promise in treating ulcerative colitis

Chinese drug 3D printing firm Triastek has concluded its First-in-Human (FIH) study of its new 3D printing drug, dubbed T21. This drug is designed to treat moderate to severe ulcerative colitis (UC). According to the study’s imaging findings, T21 tablets demonstrate accurate delivery and controlled release to the colon, where the drug is intended to […]